Who have Depression with Sandostatin - from FDA reports
Depression is found among people who take Sandostatin, especially for people who are female, 60+ old , have been taking the drug for 6 - 12 months, also take medication Norvasc, and have Neuroendocrine tumor. This study is created by eHealthMe based on reports of 25,748 people who have side effects when taking Sandostatin from FDA, and is updated regularly.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Peer to Peer mobile support
Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.
25,748 people reported to have side effects when taking Sandostatin.
Among them, 592 people (2.3%) have Depression
Number of reports submitted per year:
Time on Sandostatin when people have Depression *:
- < 1 month: 21.92 %
- 1 - 6 months: 23.29 %
- 6 - 12 months: 23.29 %
- 1 - 2 years: 15.07 %
- 2 - 5 years: 8.22 %
- 5 - 10 years: 8.22 %
- 10+ years: 0.0 %
Gender of people who have Depression when taking Sandostatin *:
- female: 63.76 %
- male: 36.24 %
Age of people who have Depression when taking Sandostatin *:
- 0-1: 0.0 %
- 2-9: 0.81 %
- 10-19: 0.27 %
- 20-29: 1.08 %
- 30-39: 5.39 %
- 40-49: 18.87 %
- 50-59: 22.1 %
- 60+: 51.48 %
Top conditions involved for these people *:
- Neuroendocrine Tumor: 138 people, 23.31%
- Pain: 86 people, 14.53%
- High Blood Pressure: 77 people, 13.01%
- Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 45 people, 7.60%
- Pancreatic Carcinoma (pancreatic cancer): 33 people, 5.57%
- Metastatic Carcinoid Tumor: 26 people, 4.39%
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 19 people, 3.21%
- Diarrhea: 14 people, 2.36%
- Diabetes: 13 people, 2.20%
- Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 12 people, 2.03%
Top co-used drugs for these people *:
- Norvasc: 48 people, 8.11%
- Afinitor: 45 people, 7.60%
- Zoloft: 32 people, 5.41%
- Protonix: 31 people, 5.24%
- Pantoprazole: 30 people, 5.07%
- Folic Acid: 28 people, 4.73%
- Vioxx: 27 people, 4.56%
- Oxycontin: 27 people, 4.56%
- Miacalcin: 26 people, 4.39%
- Questran: 26 people, 4.39%
Top other side effects for these people *:
- Diarrhea: 275 people, 46.45%
- Fatigue (feeling of tiredness): 267 people, 45.10%
- Nausea (feeling of having an urge to vomit): 211 people, 35.64%
- Weakness: 205 people, 34.63%
- High Blood Pressure: 202 people, 34.12%
- Pain: 202 people, 34.12%
- Stress And Anxiety: 200 people, 33.78%
- Malaise (a feeling of general discomfort or uneasiness): 196 people, 33.11%
- Weight Decreased: 194 people, 32.77%
- Headache (pain in head): 191 people, 32.26%
* Approximation only. Some reports may have incomplete information.
Do you have Depression while taking Sandostatin?
- Check whether a drug or a condition causes Depression
- Subscribe to monitor Depression in Sandostatin
You are not alone:
- Connect with people like you who take Sandostatin and have Depression
- Use your healthcare experience to help people like you, and be rewarded
Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. (latest outcomes from Sandostatin 25,846 users)
Depression has been reported by people with depression, multiple sclerosis, pain, quit smoking, high blood pressure (latest reports from 447,181 Depression patients).
Drugs that are associated with DepressionDepression (3,537 drugs)
Could your condition cause DepressionDepression (3,658 conditions)
Sandostatin side effects
- Sandostatin side effects (25,775 reports)
Browse by gender and age
Browse all side effects of Sandostatina b c d e f g h i j k l m n o p q r s t u v w x y z
Related publications that referenced our studies
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin® LAR® depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2013 Jan .
What would happen?
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Recent general studies
- Will you have Dry Eyes Aggravated with Tioconazole? - now
- Will you have Confusion with Triphasil-28? - 2 seconds ago
- Will you have Thinking - Unclear with Triphasil-28? - 2 seconds ago
- Will you have Disorientation with Triphasil-28? - 2 seconds ago
- Will you have Thoughts - Cloudy with Triphasil-28? - 2 seconds ago
- Will you have Waist Circumference Increased with Ventolin? - 6 seconds ago
- Will you have Disfluency with Lisinopril? - 7 seconds ago
- Will you have Hypotonia with Lupron Depot? - 7 seconds ago
- Will you have Hypotonic Infant with Lupron Depot? - 7 seconds ago
- Will you have Acne Aggravated with Oxycodone? - 7 seconds ago
Recent personal studies
- A study for a 56 year old woman who takes Avapro, Clarithromycin, Dexamethasone - 37 minutes ago
- A study for a 52 year old woman who takes Plavix, Lipitor, Clonazepam - 51 minutes ago
- A study for a 42 year old man who takes Viagra, Vyvanse - 57 minutes ago
- A study for a 34 year old man who takes Depakote - an hour ago
- A study for a 65 year old man who takes Prednisolone - 5 hours ago
- A study for a 70 year old man who takes Plaquenil - 5 hours ago
- A study for a 40 year old woman who takes Zoloft, Ativan, Topamax - 6 hours ago
- A study for a 34 year old man who takes Omega-3 Oil - 6 hours ago
- A study for a 40 year old woman who takes Adderall - 7 hours ago
- A study for a 46 year old man who takes Xopenex, Singulair - 7 hours ago
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.